Breaking News Instant updates and real-time market news.

MDT

Medtronic

$82.71

-0.6 (-0.72%)

16:34
10/14/16
10/14
16:34
10/14/16
16:34

Medtronic to recall certain lots of Pipeline, Alligator, X-Celator devices

Medtronic announced that it has notified customers of a voluntary recall of certain lots of its Pipeline embolization device, Alligator retrieval device and X-Celerator hydrophilic guidewire. The recall also includes the stylet containing UltraFlow flow directed micro catheters and Marathon flow directed micro catheters. These products are produced, marketed and sold by Medtronic's Neurovascular business, which is part of the Brain Therapies division in the company's Restorative Therapies Group. This voluntary recall is being conducted due to the potential separation and detachment of the polytetrafluoroethylene coating on parts of these devices. Should the PTFE separate from the delivery wire or stylets, PTFE particulate could enter the blood stream of the patient. PTFE in the blood stream, based on the size and quantity, could lead to a thromboembolic event. At the initiation of this recall, 84,278 units potentially affected by this recall had been distributed worldwide. The products were manufactured from July 2014 to September 2016.

  • 10

    Nov

MDT Medtronic
$82.71

-0.6 (-0.72%)

08/26/16
PIPR
08/26/16
NO CHANGE
PIPR
Medtronic guidance conservative, says Piper Jaffray
After Medtronic reported higher than expected Q1 EPS and in-line revenue, Piper Jaffray analyst Brooks West says the quarter was "just fine." He says that the company's failure to raise its revenue guidance to reflect recent acquisitions was conservative and "de-risks" its now "beatable" guidance. West expects new products to bolster the company's revenue, and he predicts that it will continue to gain share in CRM. He keeps a $104 price target and Overweight rating on the stock.
09/29/16
COWN
09/29/16
NO CHANGE
COWN
Outperform
Cowen says views on Dexcom, Insulet not changed by competitor launches
Cowen analyst Doug Schenkel noted that Abbott (ABT) announced yesterday it had received FDA approval for the professional version of its FreeStyle Libre glucose monitoring product and filed the consumer version of Libre, while Medtronic (MDT) also announced FDA approval of its 670G Hybrid Closed Loop system. Schenkel said Abbott's consumer Libre filing comes a few months ahead of his expectations but that Medtronic's timing was in-line with expectations. The analyst said the competitor announcements, which had been expected, do not change his views on DexCom (DXCM), Insulet (PODD), or Tandem Diabetes (TNDM) and he keeps Outperform ratings on all three of those stocks.
09/29/16
BARD
09/29/16
NO CHANGE
BARD
Dexcom, Insulet could be weighed down by competitive concerns, says Baird
Baird analyst Jeff Johnson said that while the FDA approvals announced yesterday for Abbott's (ABT) FreeStyle Libre Pro and Medtronic's (MDT) 670G were largely anticipated, he believes that both approvals came sooner than most expected, as did news that Abbott also recently filed for FDA approval of its consumer Libre system. The approvals could "change the narrative" in diabetes and could weigh on others in the sector in the near-term, most notably Dexcom (DXCM) and Insulet (PODD), Johnson tells investors. He keeps Neutral ratings on both and maintains an Overweight rating on Tandem Diabetes (TNDM), citing valuation for the difference.
10/05/16
WEDB
10/05/16
NO CHANGE
WEDB
Outperform
Medtronic CGM adoption could be tempered by false alarm rates, says Wedbush
Wedbush analyst Tao Levy analyzed the recently released Summary and Effectiveness Data for Medtronic's (MDT) 670G System, which he does not believe many outside of the Continuous glucose monitoring, or CGM, manufacturers have read, and came away with the belief that its new Guardian Sensor CGM standalone system suffers from a relatively large rate of false hypoglycemia alarms. While it cannot be known for sure how competitive the Guardian Sensor will be when it is eventually approved and launched in the next several months, Levy thinks elevated false alarm rates could temper adoption and that it is "too early to assume" that the product will hinder Dexcom's (DXCM) growth. The analyst keeps a Neutral rating on Medtronic and an Outperform rating on Dexcom.

TODAY'S FREE FLY STORIES

07:11
02/28/17
02/28
07:11
02/28/17
07:11
Conference/Events
JPMorgan to hold a conference »

Investment Companies…

JD

JD.com

$30.80

0.53 (1.75%)

07:11
02/28/17
02/28
07:11
02/28/17
07:11
Recommendations
JD.com analyst commentary  »

JD.com price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Mar

PCLN

Priceline

$1,632.01

0.39 (0.02%)

07:11
02/28/17
02/28
07:11
02/28/17
07:11
Recommendations
Priceline analyst commentary  »

Priceline price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CANF

Can-Fite BioPharma

$1.96

0.0024 (0.12%)

07:11
02/28/17
02/28
07:11
02/28/17
07:11
Hot Stocks
Can-Fite BioPharma: Data show Namodenoson prevents liver fibrosis progression »

Can-Fite BioPharma…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WRD

WildHorse Resource

$12.43

-0.15 (-1.19%)

07:11
02/28/17
02/28
07:11
02/28/17
07:11
Hot Stocks
WildHorse Resource reports year-end 2016 proved reserves of 152.5MMboe »

Year-End 2016 Reserves:…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Mar

  • 05

    Mar

I

Intelsat

$5.87

1.18 (25.16%)

07:11
02/28/17
02/28
07:11
02/28/17
07:11
Earnings
Intelsat sees 2017 revenue $2.18B-$2.225B, consensus $2.16B »

Intelsat forecasts…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Feb

07:10
02/28/17
02/28
07:10
02/28/17
07:10
Conference/Events
KeyBanc to hold a summit »

Emerging Technology…

SAR

Saratoga Investment

$22.22

-0.63 (-2.76%)

07:10
02/28/17
02/28
07:10
02/28/17
07:10
Hot Stocks
Saratoga Investment raises quarterly dividend to 46c per share »

Saratoga Investment…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SGMO

Sangamo

$4.30

0.3 (7.50%)

07:10
02/28/17
02/28
07:10
02/28/17
07:10
Earnings
Sangamo reports Q4 EPS (14c), consensus (25c) »

Reports Q4 revenue $8.9M,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Feb

  • 27

    Apr

I

Intelsat

$5.87

1.18 (25.16%)

07:10
02/28/17
02/28
07:10
02/28/17
07:10
Earnings
Intelsat reports Q4 EPS $5.56 vs. ($38.29) last year »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Feb

CAT

Caterpillar

$97.44

1.96 (2.05%)

, ITW

Illinois Tool Works

$131.88

0.2 (0.15%)

07:10
02/28/17
02/28
07:10
02/28/17
07:10
Conference/Events
Evercore ISI to hold a conference »

Annual Industrials…

CAT

Caterpillar

$97.44

1.96 (2.05%)

ITW

Illinois Tool Works

$131.88

0.2 (0.15%)

URI

United Rentals

$128.21

4.06 (3.27%)

KMT

Kennametal

$37.71

0.08 (0.21%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Feb

  • 07

    Mar

  • 07

    Mar

  • 14

    Jun

PRXL

PAREXEL

$66.26

0.32 (0.49%)

, GSK

GlaxoSmithKline

$41.57

0.01 (0.02%)

07:10
02/28/17
02/28
07:10
02/28/17
07:10
Hot Stocks
PAREXEL names SImon Harford as SVP, CFOG »

PAREXEL International…

PRXL

PAREXEL

$66.26

0.32 (0.49%)

GSK

GlaxoSmithKline

$41.57

0.01 (0.02%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Mar

  • 14

    Mar

07:09
02/28/17
02/28
07:09
02/28/17
07:09
Conference/Events
Credit Suisse to hold a conference »

2017 Global Healthcare…

IONS

Ionis Pharmaceuticals

$46.90

2.31 (5.18%)

07:09
02/28/17
02/28
07:09
02/28/17
07:09
Earnings
Ionis Pharma reports Q4 GAAP EPS 21c, may not compare with consensus (12c) »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Feb

SAR

Saratoga Investment

$22.22

-0.63 (-2.76%)

07:09
02/28/17
02/28
07:09
02/28/17
07:09
Hot Stocks
Saratoga Investment raises quarterly dividend to 46c per share »

Saratoga Investment…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MDCO

The Medicines Co.

$53.22

1.16 (2.23%)

07:08
02/28/17
02/28
07:08
02/28/17
07:08
Earnings
The Medicines Co. reports Q4 adjusted EPS ($1.19), consensus ($1.43) »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Feb

FEYE

FireEye

$11.50

0.26 (2.31%)

, PI

Impinj

$29.12

-0.87 (-2.90%)

07:08
02/28/17
02/28
07:08
02/28/17
07:08
Conference/Events
Pacific Crest to hold a summit »

12th Annual Pacific Crest…

FEYE

FireEye

$11.50

0.26 (2.31%)

PI

Impinj

$29.12

-0.87 (-2.90%)

BL

BlackLine

$29.56

-0.36 (-1.20%)

FB

Facebook

$136.41

0.97 (0.72%)

MB

MINDBODY

$27.05

1.1 (4.24%)

PCTY

Paylocity

$36.41

-0.37 (-1.01%)

AZPN

Aspen Technology

$59.00

0.63 (1.08%)

ECOM

ChannelAdvisor

$10.75

-0.4 (-3.59%)

DATA

Tableau

$53.58

0.32 (0.60%)

CTXS

Citrix

$80.16

-0.02 (-0.02%)

GRPN

Groupon

$4.49

0.02 (0.45%)

CYBR

CyberArk

$50.60

0.07 (0.14%)

PFPT

Proofpoint

$79.35

-0.29 (-0.36%)

WDAY

Workday

$90.19

0.53 (0.59%)

ULTI

Ultimate Software

$199.17

0.81 (0.41%)

AMBR

Amber Road

$7.75

-0.1 (-1.27%)

VEEV

Veeva

$44.14

-0.07 (-0.16%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Feb

  • 28

    Feb

  • 28

    Feb

  • 28

    Feb

  • 28

    Feb

  • 28

    Feb

  • 01

    Mar

  • 02

    Mar

  • 05

    Mar

  • 06

    Mar

  • 07

    Mar

  • 08

    Mar

  • 09

    Mar

  • 10

    Mar

  • 13

    Mar

  • 14

    Mar

  • 19

    Mar

  • 22

    Mar

  • 23

    Mar

  • 24

    Mar

  • 28

    Mar

SXL

Sunoco Logistics

$25.23

-0.04 (-0.16%)

07:08
02/28/17
02/28
07:08
02/28/17
07:08
Initiation
Sunoco Logistics initiated  »

Sunoco Logistics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WDAY

Workday

07:08
02/28/17
02/28
07:08
02/28/17
07:08
Downgrade
Workday rating change  »

Workday downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Feb

  • 28

    Feb

  • 01

    Mar

  • 02

    Mar

  • 13

    Mar

  • 14

    Mar

NXST

Nexstar

$70.20

0.45 (0.65%)

07:07
02/28/17
02/28
07:07
02/28/17
07:07
Earnings
Nexstar reports Q4 EPS 64c including items, consensus $1.38 »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Feb

  • 06

    Mar

VRX

Valeant

$16.71

0.53 (3.28%)

07:07
02/28/17
02/28
07:07
02/28/17
07:07
Hot Stocks
Valeant CEO says 'well poised for turnaround in 2017' »

"Today, we announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Feb

  • 02

    Mar

  • 14

    Mar

ROYT

Pacific Coast Oil

$1.94

0.02 (1.04%)

07:07
02/28/17
02/28
07:07
02/28/17
07:07
Downgrade
Pacific Coast Oil rating change  »

Pacific Coast Oil…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XXII

22nd Century

$0.96

-0.016 (-1.63%)

07:06
02/28/17
02/28
07:06
02/28/17
07:06
Hot Stocks
22nd Century receives feedback from FDA regarding MRTP application »

22nd Century Group…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NYLD

NRG Yield

$17.55

-0.19 (-1.07%)

07:05
02/28/17
02/28
07:05
02/28/17
07:05
Hot Stocks
NRG Yield reconfirms 2017 outlook »

NRG Yield is reconfirming…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Feb

TA

TravelCenters

$7.45

0.15 (2.05%)

07:05
02/28/17
02/28
07:05
02/28/17
07:05
Earnings
TravelCenters reports Q4 EPS (17c), consensus (6c) »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Feb

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.